Clinical Trials Directory

Trials / Completed

CompletedNCT03482921

Body Parameters as an Independent Predictor of Acute Pancreatitis

Body Parameters as an Independent Predictor of Acute Pancreatitis: A Propensity Score-matched Case-control Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,662 (actual)
Sponsor
Ningbo No. 1 Hospital · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

This study is to assess the predictive significance of visceral adipose tissue (VAT) and visceral adipose tissue /skeletal muscle tissue ratio (VAT/SMT ratio) for the prognosis in acute pancreatitis (AP) patients.

Detailed description

Acute pancreatitis (AP) is a sudden inflammation of the pancreas. However, one-fifth of patients may develop severe complications with a mortality between 10%-20% It remains a difficulty to find an effective method for prediction of severity of AP at early stage. It is well-established that obesity (defined as body mass index\[BMI\]\>30kg/m2 by the World Health Organization) is a risk factor for AP and increases the incidence of systemic complication, motality. There are a lot of parameters related to saropenic obesity, including areas of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), skeletal muscle tissue (SMT), and VAT/SMT ratio. it is unclear which parameter is the best predictor of severe AP. Thus, this study is aimed to investigate the association between these parameters and AP severity and find the best predictor of AP.

Conditions

Timeline

Start date
2017-12-01
Primary completion
2018-02-12
Completion
2018-03-22
First posted
2018-03-29
Last updated
2018-03-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03482921. Inclusion in this directory is not an endorsement.